These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 1631999)
21. Use of surfactant for prophylaxis versus rescue treatment of respiratory distress syndrome: experience from an Italian-Bulgarian trial. Bevilacqua G; Chernev T; Parmigiani S; Iarakova N; Gaioni L; Volante E; Gambini L; Bussolati G Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():47-54. PubMed ID: 10021717 [TBL] [Abstract][Full Text] [Related]
22. Total antioxidant capacity and total oxidant status after surfactant treatment in preterm infants with respiratory distress syndrome. Dizdar EA; Uras N; Oguz S; Erdeve O; Sari FN; Aydemir C; Dilmen U Ann Clin Biochem; 2011 Sep; 48(Pt 5):462-7. PubMed ID: 21775575 [TBL] [Abstract][Full Text] [Related]
23. Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants. Proquitté H; Dushe T; Hammer H; Rüdiger M; Schmalisch G; Wauer RR Respir Med; 2007 Jan; 101(1):169-76. PubMed ID: 16698258 [TBL] [Abstract][Full Text] [Related]
24. [Surfactant replacement therapy for respiratory distress syndrome: a pilot study]. Shinwell ES; Zmora E; Leven D; Berger I; Karplus M Harefuah; 1992 Jul; 123(1-2):1-4, 72. PubMed ID: 1505835 [TBL] [Abstract][Full Text] [Related]
25. Use of surfactant in the prevention and treatment of neonatal respiratory distress syndrome. Reynolds MS; Wallander KA Clin Pharm; 1989 Aug; 8(8):559-76. PubMed ID: 2670398 [TBL] [Abstract][Full Text] [Related]
26. [Surfactant therapy of premature infants. Complications and mortality are reduced]. Hjalmarson O Lakartidningen; 1993 Nov; 90(45):3938-40. PubMed ID: 8231562 [No Abstract] [Full Text] [Related]
27. [Effect of 2 different dosages of a porcine surfactant on pulmonary gas exchange of premature infants with severe respiratory distress syndrome]. Herting E; Tubman R; Halliday HL; Harms K; Speer CP; Curstedt T; Robertson B Monatsschr Kinderheilkd; 1993 Sep; 141(9):721-7. PubMed ID: 8413348 [TBL] [Abstract][Full Text] [Related]
28. An observational study of surfactant treatment in infants of 23-30 weeks' gestation: comparison of prophylaxis and early rescue. Bevilacqua G; Parmigiani S; J Matern Fetal Neonatal Med; 2003 Sep; 14(3):197-204. PubMed ID: 14694975 [TBL] [Abstract][Full Text] [Related]
29. Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome. Fujii AM; Patel SM; Allen R; Doros G; Guo CY; Testa S J Perinatol; 2010 Oct; 30(10):665-70. PubMed ID: 20336076 [TBL] [Abstract][Full Text] [Related]
30. Surfactant replacement in preterm infants with respiratory distress syndrome. Dani C Acta Biomed; 2012; 83 Suppl 1():17-20. PubMed ID: 23029871 [TBL] [Abstract][Full Text] [Related]
31. [Early selective surfactant treatment--also to very premature infants treated with CPAP?]. Klamer A; Greisen G Ugeskr Laeger; 2001 Dec; 163(50):7053-6. PubMed ID: 11794037 [TBL] [Abstract][Full Text] [Related]
32. Functional residual capacity and compliance of the respiratory system after surfactant treatment in premature infants with severe respiratory distress syndrome. Dinger J; Töpfer A; Schaller P; Schwarze R Eur J Pediatr; 2002 Sep; 161(9):485-90. PubMed ID: 12200607 [TBL] [Abstract][Full Text] [Related]
33. [Natural surfactant in routine treatment of neonatal respiratory distress syndrome. Experiences from two central hospitals]. Grønn M; Silberg IE Tidsskr Nor Laegeforen; 1997 Apr; 117(10):1453-6. PubMed ID: 9198921 [TBL] [Abstract][Full Text] [Related]
34. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Engle WA; Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434 [TBL] [Abstract][Full Text] [Related]
35. Functional residual capacity and static compliance during the first year in preterm infants treated with surfactant. de Winter JP; Merth IT; Brand R; Quanjer PH Am J Perinatol; 2000; 17(7):377-84. PubMed ID: 12141525 [TBL] [Abstract][Full Text] [Related]
36. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Speer CP; Robertson B; Curstedt T; Halliday HL; Compagnone D; Gefeller O; Harms K; Herting E; McClure G; Reid M Pediatrics; 1992 Jan; 89(1):13-20. PubMed ID: 1727997 [TBL] [Abstract][Full Text] [Related]
37. Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial. Egberts J; de Winter JP; Sedin G; de Kleine MJ; Broberger U; van Bel F; Curstedt T; Robertson B Pediatrics; 1993 Dec; 92(6):768-74. PubMed ID: 8233735 [TBL] [Abstract][Full Text] [Related]
38. [Surfactant treatment of premature infants with respiratory distress syndrome]. Lindemann R; Grøgaard J Tidsskr Nor Laegeforen; 1991 Mar; 111(8):1032-3. PubMed ID: 2042202 [No Abstract] [Full Text] [Related]
39. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150 [TBL] [Abstract][Full Text] [Related]
40. Morbidity and mortality of neonatal respiratory failure in China: surfactant treatment in very immature infants. Wang H; Gao X; Liu C; Yan C; Lin X; Yang C; Lin Z; Zhu W; Yang Z; Yu F; Qiu Y; Liu X; Zhou X; Chen C; Sun B; Pediatrics; 2012 Mar; 129(3):e731-40. PubMed ID: 22331337 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]